The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients (THROM-CRIT)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Wincy Ng, MRCP
- Phone Number: 22553111
- Email: wincyngwingsze@gmail.com
Study Locations
-
-
-
Hong Kong, Hong Kong
- Queen Mary Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≧ 18; AND
- Admitted to the mixed medical-surgical intensive care units of Queen Mary Hospital in Hong Kong; AND
- Clinically indicated for central catheter insertion, which includes central venous catheters and dialysis catheters; AND
- Expected to have the central catheter in place for at least 5 days in their ICU stay.
Exclusion Criteria:
- Patients known to have active venous thromboembolism including deep venous thrombosis or pulmonary embolism;
- Patients known to have hypercoagulable states, e.g., hereditary thrombophilia, antiphospholipid syndrome; OR
- Patients with active solid organ or hematological malignancies; OR
- Patients already receiving therapeutic anticoagulation prior to study recruitment; OR
- Patients with thrombosis detected in the insertion site before central catheter insertion; OR
- Patients with a central venous catheter already in place prior to ICU admission; OR
- Patients admitted to the ICU for post-operative care; OR
- Patients admitted to the ICU for trauma care; OR
- Patients requiring extra-corporeal life support (ECLS); OR
- Patients with poor window or inaccessible for ultrasonographic examination; OR
- Pregnancy/post-partum within 6 weeks
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in peak thrombin generation (nM) between patients with and without central line related thrombosis
Time Frame: From the time of CVC insertion to the time of CVC removal
|
The primary outcome measure is the difference in peak thrombin generation (nM) between patients with and without central line related thrombosis
|
From the time of CVC insertion to the time of CVC removal
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 20230905-017-000
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.